Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

662.00
-5.4849-0.82%
Number of Gainers:66
Number of Losers:74
Number of Flat:13
PE:- -
High:667.46
Open:667.46
Low:652.47
Close:667.48
Volume:402.90M
Turnover:10.20B
Market Cap:458.70B
Float Cap:351.94B

Loading ...

Travere Therapeutics announces FILSPARI data presentations at ASN Kidney Week

TIPRANKS
·
Oct 02

Why Tesla Stock Is Surging Today as AppLovin Slips — and What Wall Street Expects Next

TIPRANKS
·
Oct 02

Alkami’s MANTL Unit Hosts Webinar with Grow Financial on Connected Origination Driving 3X Account-Opening Volume Growth

Reuters
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)

TIPRANKS
·
Oct 02

Piper Sandler Adjusts Coinbase Global Price Target to $170 From $146, Maintains Neutral Rating

MT Newswires Live
·
Oct 02

Coinbase Global up 5.1%, Strategy Gains 5.6%

THOMSON REUTERS
·
Oct 02

Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026

Reuters
·
Oct 02

Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk

Reuters
·
Oct 02

Intapp CEO John T. Hall Disposes of 3,000 Common Shares Worth $81,024

Reuters
·
Oct 02

Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients

Reuters
·
Oct 02

Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026

Reuters
·
Oct 02

Candel Therapeutics to Present at the SITC 2026 Annual Meeting

GlobeNewswire
·
Oct 02

Kanzhun Updates Share Capital and Corrects RSU Disclosures Following Late-September Transactions

TIPRANKS
·
Oct 02

Don’t Miss These 4 Stocks in the AI Infrastructure Race

InvestorPlace
·
Oct 02

Dingdong Refreshes Board with New Independent Director After September Resignation

TIPRANKS
·
Oct 02

U.S. Stocks on the MOVE-Moderna, Nike, Synaptics

Reuters
·
Oct 02

Century Therapeutics: Cnty-813 Ind Submission Remains on Track for Q4 2026; Initial Clinical Data Anticipated in Second Half of 2027 - SEC Filing

THOMSON REUTERS
·
Oct 02

Century Therapeutics announces presentation of nonclinical data for CNTY-813

TIPRANKS
·
Oct 02

Wall Street Analysts Are Bullish on Top Financial Picks

TIPRANKS
·
Oct 02

Century Therapeutics Targets CNTY-813 IND Filing in Q4 2026, Sees Initial Trial Data in 2H 2027

Reuters
·
Oct 02